CompaniesCellestis

Cellestis

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

0

As Collaborator

3

Total Enrollment

891

By Phase

PHASE4: 1NA: 1

By Status

COMPLETED: 2WITHDRAWN: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT00168259
NCT00424684
NCT01223534
Hover over trial bars to see details

Recent Trials

NCT01223534Collaborator
QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.
PHASE4Completed
871 participants
Started: Jul 31, 2010 · Completed: Feb 29, 2016
NCT00424684Collaborator
Comparison of the Quantiferon®-TB GOLD (in Tube) Assay With Tuberculin Skin Testing for Detecting Latent Tuberculosis Infection in Patients With Chronic Liver Disease Being Evaluated for or Awaiting Liver Transplantation
NAWithdrawn
Started: Jan 31, 2007
NCT00168259Collaborator
Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals
N/ACompleted
20 participants
Started: Dec 31, 2004 · Completed: Dec 31, 2009
Related Companies
Qiagen Aug 2011----------------------------------------if You Believe Any Of This Information Is Incorrect
acquired